2,324 results match your criteria: "Minneapolis Heart institute[Affiliation]"
Catheter Cardiovasc Interv
November 2024
McGovern School of Medicine, Department of Cardiology, University of Texas, Houston, Texas, USA.
Background: Intraplaque delivery of contrast has been utilized during percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) to delineate anatomy and to facilitate wire crossing. Its utility as a tool to accomplish primary crossing of CTOs has not been described or validated.
Aims: We describe a new technique leveraging the diagnostic and therapeutic roles of intraplaque contrast injection to accomplish primary crossing of CTOs: HydroDynamic contrast Recanalization (HDR).
J Endovasc Ther
September 2024
University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Objectives: To evaluate outcomes of patients with complex aortic aneurysms (cAAs) undergoing fenestrated/branched endovascular aortic aneurysm repair (f/b-EVAR) using a combination of endoprostheses from different manufacturers.
Methods: The study is a 2-center retrospective analysis of prospectively maintained databases of patients with cAAs undergoing f/b-EVAR using a combination of endoprostheses from different manufacturers from 2013 to 2023. Primary endpoints included technical success, major adverse events and reintervention rates.
JACC Cardiovasc Interv
September 2024
HerzZentrum Hirslanden, Zurich, Switzerland.
Background: Transcatheter tricuspid valve intervention (TTVI) has been increasingly adopted in recent years for the treatment of patients with tricuspid regurgitation (TR). However, no dedicated risk stratification has been established for patients undergoing TTVI.
Objectives: The aim of the present study was to propose a dedicated risk score for patients affected by severe TR undergoing TTVI.
Atherosclerosis
November 2024
CORRIB Research Centre for Advanced Imaging and Core Lab, University of Galway, Galway, Ireland. Electronic address:
Circulation
December 2024
Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus (W.T.A.).
J Cardiovasc Magn Reson
September 2024
Minneapolis Heart Institute, Minneapolis, Minnesota, USA. Electronic address:
JACC Cardiovasc Interv
October 2024
University Hospital Basel, Basel, Switzerland.
Eur Heart J Cardiovasc Imaging
December 2024
Minneapolis Heart Institute Foundation and the Valve Science Center, Minneapolis, MN, USA.
Aims: Degenerative mitral stenosis (DMS) is due to degenerative mitral annular calcification (MAC) and valvular calcification. However, DMS impacts on the outcome, and therefore, potential treatment needs are poorly known. We aimed at evaluating survival after DMS diagnosis by Doppler echocardiography in routine practice.
View Article and Find Full Text PDFJACC Case Rep
August 2024
Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
JACC Case Rep
August 2024
Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
JACC Case Rep
August 2024
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
JACC Adv
October 2024
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
Background: During takotsubo syndrome (TS), QTc prolongation is common, reflecting repolarization injury and providing the substrate for torsades de pointes (TdP). TdP has been reported sporadically in TS, yet QTc prolongation and TdP risk are often overlooked during management.
Objectives: In TS patients, we sought to document TdP incidence, characteristics of patients with TdP, and association of QTc with postdischarge survival.
JACC Adv
October 2024
Institut Universitaire de Cardiologie et de Pneumologie, Université Laval, Québec, Canada.
Background: In patients with low-gradient (LG) aortic stenosis (AS), confirming disease severity and indication of intervention often requires dobutamine stress echocardiography (DSE) or aortic valve calcium scoring by computed tomography. We hypothesized that the mean transvalvular pressure gradient to effective orifice area ratio (MG/EOA, in mm Hg/cm) measured during rest echocardiography identifies true-severe AS (TSAS) and is associated with clinical outcomes in patients with low-flow, LG-AS.
Objectives: The purpose of this study was to evaluate the diagnostic and prognostic value of MG/EOA ratio.
JACC Adv
October 2024
Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Background: Compared to normal high-density lipoprotein (HDL) cholesterol values, very high HDL cholesterol is associated with a higher incidence of mortality and atherosclerotic cardiovascular disease (ASCVD). As such, clinical risk stratification among persons with very high HDL cholesterol is challenging.
Objectives: Among persons with very high HDL cholesterol, the purpose was to determine the prevalence of coronary artery calcium (CAC) and compare the association between traditional risk factors vs CAC for all-cause mortality and ASCVD.
Eur Heart J
October 2024
Department of Cardiothoracic Surgery, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Circulation
October 2024
Texas Cardiac Arrhythmia Research Foundation, Austin (A.N.).
Background: Evidence from clinical trials of early pulsed field ablation (PFA) systems in treating atrial fibrillation has demonstrated their promising potential to reduce complications associated with conventional thermal modalities while maintaining efficacy. However, the lack of a fully integrated mapping system, a staple technology of most modern electrophysiology procedures, poses limitations in lesion creation and workflow options. A novel variable-loop PFA catheter integrated with an electroanatomic mapping system has been developed that allows for real-time nonfluoroscopic procedural guidance and lesion indexing as well as feedback of tissue-to-catheter proximity.
View Article and Find Full Text PDFCardiooncology
September 2024
Division of Medicine, Federal University of Campina Grande, 795 Juvêncio Arruda Avenue, Campina Grande, Brazil.
Background: Patients with active cancer and aortic stenosis may be under-referred for valve interventions due to concerns over a prohibitive risk. However, whether active cancer impacts outcomes after transcatheter aortic valve replacement (TAVR) remains unknown.
Methods: We searched PubMed, Embase, and Cochrane Library in December 2023 for studies comparing the post-TAVR outcomes of patients with versus without active cancer.
JACC Cardiovasc Interv
September 2024
New York Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA.
Background: Tricuspid regurgitation (TR) is a common valve disease that has a significant impact on patients' quality of life.
Objectives: This study sought to report the final 3-year outcomes of tricuspid transcatheter edge-to-edge repair (T-TEER) with the TriClip (Abbott) implant from the TRILUMINATE (TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR) study for the treatment of severe symptomatic TR.
Methods: The TRILUMINATE study (N = 98 subjects) is an international, prospective, single-arm, multicenter study to investigate the safety and performance of T-TEER with the TriClip implant in patients with symptomatic moderate or greater TR.
J Am Soc Echocardiogr
September 2024
Cleveland Clinic, Cleveland, Ohio.
J Am Coll Cardiol
November 2024
Heart Institute, InCor, University of São Paulo Medical School, São Paulo, SP, Brazil.
J Am Coll Cardiol
December 2024
Mount Sinai, New York, New York, USA.
Heart Rhythm
August 2024
Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California.
Am J Cardiol
November 2024
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:
Int J Cardiol
December 2024
Cardiovascular Imaging Research Center, Minneapolis Heart Institute and Foundation, Minneapolis, MN, United States of America; Cardiovascular Imaging Unit, Cardiothoracic Department, IRCCS San Raffaele Scientific Institue, Milan, Italy. Electronic address:
Eur Heart J
November 2024
Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, Canada.
Background And Aims: Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient subsets who might benefit from the surgery.
Methods: In TRIGISTRY, an international cohort study of consecutive patients with severe isolated functional tricuspid regurgitation (33 centres, 10 countries), survival rates up to 10 years were compared between patients who underwent isolated tricuspid valve surgery (repair or replacement) and those conservatively managed, overall and according to TRI-SCORE category (low: ≤3, intermediate: 4-5, and high: ≥6).